2Hsiu HI,Lin LC,Lee FR,et al.Changes of hepaticandsys-temichemodynamics following somatostatin administration inpatients with hepatitis related cirrhosis.JG astroenterol,1993,8(1):154.
3Barris T,Borderie C,Strock P,et al.Effdets of octreotide on lower esophageal sphincted in patients with cirrhosis and portol hypertension.Digdis Sci,1998,43(7):1566.
1Sanguineti G, Endres EJ, Parker BC, et al. Acute toxicity of whole-pelvis IMRT in 87 patients with localized prostate cancer[J].Acta Oncol,2008,47(2) :301-310.
2Mercadantc S,Ripamonti C, Casuccio A, et al. Comparison of oclreotide and hyoscinc bulylbromide in controlling gastrointestinal symploms due to malignant inoperable bowel obstruction[J]. Support Care Canccr,2008(3) : 188--191.
3Wedlake L,Thomas K, McGough C,et al. Small bowel bacterial overgrowth and lactose intolerance during radical pelvic radiotherapy: An observational study[J].Eur J Cancer, 2008, 44(15) :2212-2217.
4Ippoliti C, Champlin R, Bugazia, N, et al. (1997) Use of oct reotide in the symptomatic management of diarrhea induced by graftversus-host disease in patienls with hematologic malignancies[J]. J Clin Oncol,2005( 11 ) :3350-3354.
5Martcnson JA, Halyard MY,Sloan JA,et al. Phase III,doubleblind study of depot octreotide versus placebo in the prevention of acute diarrhea in patients receiving pelvic radiation therapy: results of North Central Cancer Treatment Group N00CA[J]. J Clin Oncol,2008,26(32) :5248-5253.
6Yavuz MN, Yavuz AA, Aydin F,el al. The efficacy of octreoti de in the therapy of acute radiation-induced diarrhea: a randomized conlrolled study[J].Int J Radiat Oncol Biol Phys, 2002,54(1 ) : 195-202.
7谷铣之,殷蔚伯,余子豪,等.肿瘤放射治疗学[M].4版:中国协和医科大学出版社,2007:7.
8Al B, Benson IlI,Jaffer A,et al. Recommended guidelines for the treatment of cancer treatment-induced diarrhea[J].J Clin Oncol, 2004,22 ( 14 ) : 2918-2926.
9Ashley AC, Sargent DJ, Alberts SR, et al. Updated efficacy and toxicity analysis of irinotecan and oxaliplatin (1ROX) : intergroup trial N9741 in first-line treatment of metastatic colorectal cancer[J].Cancer,2007,110(3) :670-6777.
